Cytosorbents Corp Shares Close the Day 10.1% Lower - Daily Wrap
The company saw its shares close the day 10.1% lower than yesterday, with trading volume lower than its 30 day average.
Jan 16, 2022 by Kwhen Finance Editors
Cytosorbents Corp (CTSO) shares closed today 10.1% lower than it did at the end of yesterday. The stock is currently down 23.2% year-to-date, down 63.5% over the past 12 months, and down 44.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%.
Trading Activity
- Shares traded as high as $4.09 and as low as $3.18 this week.
- Shares closed 72.4% below its 52-week high and 1.3% above its 52-week low.
- Trading volume this week was 49.8% lower than the 10-day average and 59.6% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cytosorbents Corp | -10.1 | -23.2 | -63.5 | -69.3 | 12.6 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 17.8 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 24.4 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.7 | 12.9 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 1069.0%
- The company's stock price performance over the past 12 months lags the peer average by 815.0%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cytosorbents Corp | CTSO | 0 | -23.2 | -63.5 | -69.3 | 12.6 |
| Peer Avg | N/A | 11.5 | -2.0 | -6.9 | -24.2 | 16.4 |
| Boston Scientific Corp. | BSX | 58.1 | 5.6 | 24.1 | -4.6 | 26.0 |
| Hologic, Inc. | HOLX | 4.7 | -9.1 | -9.0 | -18.1 | 15.8 |
| Meridian Bioscience Inc. | VIVO | 6.3 | 2.1 | -5.9 | -32.8 | 21.1 |
| Nephros Inc | NEPH | 0 | -11.0 | -34.4 | -54.1 | 3.1 |
| Daxor Corporation | DXR | 0 | 0.6 | -16.4 | -35.4 | 32.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: